•
Sep 30, 2021

Altria Q3 2021 Earnings Report

Altria balanced maximizing profitability from core tobacco businesses with investing in smoke-free transition and expanded share repurchase program.

Key Takeaways

Altria reported a decrease in net revenues but an increase in adjusted diluted EPS. The company expanded its share repurchase program and narrowed its full-year earnings guidance.

Altria continued to balance maximizing profitability from its core tobacco businesses with investing to realize its Vision of responsibly leading the transition of adult smokers to a smoke-free future.

Tobacco businesses performed well against difficult year-over-year comparisons and Altria is encouraged by the significant retail share growth from on! in the third quarter.

Altria continued to reward shareholders with a strong and growing dividend and announced the expansion of its existing $2.0 billion share repurchase program to $3.5 billion.

Altria is raising the lower-end of its full-year 2021 guidance and now expect to deliver adjusted diluted EPS in a range of $4.58 to $4.62.

Total Revenue
$5.53B
Previous year: $5.68B
-2.6%
EPS
$1.22
Previous year: $1.19
+2.5%
Marlboro Retail Share
43.2%
Previous year: 43.3%
-0.2%
Gross Profit
$3.67B
Previous year: $3.72B
-1.2%
Cash and Equivalents
$2.96B
Previous year: $4.12B
-28.3%
Free Cash Flow
$3.01B
Previous year: $842M
+258.0%
Total Assets
$39.6B
Previous year: $46.7B
-15.2%

Altria

Altria

Altria Revenue by Segment

Forward Guidance

Altria narrows its guidance for 2021 full-year adjusted diluted EPS to be in a range of $4.58 to $4.62, representing a growth rate of 5% to 6% from an adjusted diluted EPS base of $4.36 in 2020.

Positive Outlook

  • Planned investments in support of its Vision
  • Marketplace investments to expand the availability and awareness of Altria’s smoke-free products
  • Costs associated with building an industry-leading consumer engagement platform that enhances data collection and insights in support of ATC transition to smoke-free products
  • Increased smoke-free product research and development expense
  • Full-year adjusted effective tax rate will be in a range of 24.5% to 25.5%

Challenges Ahead

  • Conditions related to the economy (including unemployment rates and the impact of increased inflation)
  • ATC dynamics, including stay-at-home practices, disposable income, purchasing patterns and adoption of smoke-free products
  • Regulatory and legislative (including excise tax) developments
  • Timing and extent of COVID-19 vaccine administration and the impact of COVID-19 variants
  • External environment remains dynamic

Revenue & Expenses

Visualization of income flow from segment revenue to net income